American Century Companies’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.3M | Buy |
+679,857
| New | +$21.3M | 0.01% | 1062 |
|
2024
Q3 | – | Sell |
-5,979
| Closed | -$233K | – | 2967 |
|
2024
Q2 | $233K | Sell |
5,979
-3,676
| -38% | -$143K | ﹤0.01% | 2697 |
|
2024
Q1 | $416K | Buy |
9,655
+2,456
| +34% | +$106K | ﹤0.01% | 2516 |
|
2023
Q4 | $332K | Buy |
+7,199
| New | +$332K | ﹤0.01% | 2521 |
|
2023
Q2 | – | Sell |
-9,474
| Closed | -$337K | – | 2850 |
|
2023
Q1 | $337K | Sell |
9,474
-1,531
| -14% | -$54.5K | ﹤0.01% | 2265 |
|
2022
Q4 | $434K | Buy |
11,005
+4,335
| +65% | +$171K | ﹤0.01% | 2093 |
|
2022
Q3 | $241K | Buy |
+6,670
| New | +$241K | ﹤0.01% | 2178 |
|